2. Rieder, HL. Epidemiologic Basis of Tuberculosis Control, 1st edn. Paris: International Union Against Tuberculosis and Lung Disease, 1999, pp. 12.
3. Lefebvre, N, Falzon, D. Risk factors for death among tuberculosis cases: analysis of European surveillance data. European Respiratory Journal 2008; 31: 1256–1260.
4. Bakhshi, SS, Hawker, J, Ali, S. Tuberculosis mortality in notified cases from 1989–1995 in Birmingham. Public Health 1998; 112: 165–168.
5. Zahar, JR, et al. Delayed treatment contributes to mortality in ICU patients with severe active pulmonary tuberculosis and acute respiratory failure. Intensive Care Medicine 2001; 27: 513–520.
6. Thomas, C. A literature review of the problems of delayed presentation for treatment and non-completion of treatment for tuberculosis in less developed countries and ways of addressing these problems using particular implementations of the DOTS strategy. Journal of Management in Medicine 2002; 16: 371–400.
7. Sarmiento, K, et al. Help-seeking behavior of marginalized groups: a study of TB patients in Harlem, New York. International Journal of Tuberculosis and Lung Disease 2006; 10: 1140–1145.
8. Golub, JE, et al. Patient and health care system delays in pulmonary tuberculosis diagnosis in a low-incidence state. International Journal of Tuberculosis and Lung Disease 2005; 9: 992–998.
9. Asch, S, et al. Why do symptomatic patients delay obtaining care for tuberculosis? American Journal of Respiratory and Critical Care Medicine 1998; 157: 1244–1248.
10. Sherman, LF, et al. Patient and health care system delays in the diagnosis and treatment of tuberculosis. International Journal of Tuberculosis and Lung Disease 1999; 3: 1088–1095.
11. Ohmori, M, et al. Trends of delays in tuberculosis case finding in Japan and associated factors. International Journal of Tuberculosis and Lung Disease 2005; 9: 999–1005.
12. Greenaway, C, et al. Delay in diagnosis among hospitalized patients with active tuberculosis – predictors and outcomes. American Journal of Respiratory and Critical Care Medicine 2002; 165: 927–933.
13. Rodger, A, et al. Delay in the diagnosis of pulmonary tuberculosis, London, 1998–2000: analysis of surveillance data. British Medical Journal 2003; 326: 909–910.
14. Paynter, S, et al. Patient and health service delays in initiating treatment for patients with pulmonary tuberculosis: retrospective cohort study. International Journal of Tuberculosis and Lung Disease 2004; 8: 180–185.
15. Wares, DF, Ormerod, LP, Morton, S. Delay in diagnosis of tuberculosis: of remaining concern in England and Wales. Journal of Public Health Medicine 1999; 21: 355–356.
17. Stata Corporation. Stata version 9, Stata Corp. LP, College Station, TX, USA, 2005.
18. Pirkis, JE, et al. Time to initiation of anti-tuberculosis treatment. Tubercle and Lung Disease 1996; 77: 401–406.
19. Farah, MG, et al. Patient and health care system delays in the start of tuberculosis treatment in Norway. BMC Infectious Diseases 2006; 6: 33–39.
20. Cooke, G, et al. Impact on and use of an inner-city London Infectious Diseases Department by international migrants: a questionnaire survey. BMC Health Services Research 2007; 7: 113–119.
21. Story, A, et al. Tuberculosis in London – the importance of homelessness, problem drug use and prison. Thorax 2007; 62: 667–671.
22. Galobardes, B, et al. Indicators of socio-economic position (part 2). Journal of Epidemiology and Community Health 2006; 60: 95–101.
23. Strong, M, Maheswaran, R, Pearson, T. A comparison of methods for calculating general practice level socio-economic deprivation. International Journal of Health Geographics 2006; 5: 29–33.
24. Woods, LM, et al. Geographical variation in life expectancy at birth in England and Wales is largely explained by deprivation. Journal of Epidemiology and Community Health 2005; 59: 115–120.